Condition: Atopic Dermatitis · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and pediatric participants with atopic dermatitis. The primary safety objective of this study is to compare the safety profile of ShA9 to placebo (vehicle) over 14 weeks of application, which includes an initial two-week period of co-treatment with topical corticosteroids (TCS). The primary efficacy objective of this study is to assess the ability of ShA9, compared to placebo (vehicle), to prolong the period of atopic dermatitis control over 12 weeks after conclusion of an initial two-week period of co-treatment with TCS.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of California, San Diego: Dermatology Clinical Trials Unit | San Diego, California, United States | Recruiting |
| National Jewish Health: Division of Pediatric Allergy and Clinical Immunology | Denver, Colorado, United States | Recruiting |
| Northwestern University Feinberg School of Medicine: Department of Dermatology | Chicago, Illinois, United States | Recruiting |
| New York University Langone Health: Department of Pediatric Allergy and Immunology | New York, New York, United States | Terminated |
| Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology | New York, New York, United States | Recruiting |
| University of Rochester Medical Center: Department of Dermatology | Rochester, New York, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center: Asthma Center | Cincinnati, Ohio, United States | Recruiting |
| University of Wisconsin School of Medicine and Public Health: Division of Pediatric Allergy, Immunology and Rheumatology | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06504160